application | CPI-444 is an effective selective A2A receptor (A2AR) inhibitor to induce anti-tumor response. |
use | CPI-444 is an oral antagonist of A2A receptor, which binds to adenosine receptor on the surface of immune cells. |
biological activity | Ciforadenant(CPI-444, V81444) is an effective selective Adenosine A2A receptor antagonist, which binds to A2AR with a Ki value of 3.54 nM, and its selectivity to A2AR is more than 50 times higher than that of other adenosine receptor subtypes. |
target | TargetValue A2AR () 3.54 nM(Ki) |
Target | Value |
A2AR
()
| 3.54 nM(Ki) |